Clinical Trial Update: Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a fixed-dose combination tablet of macitentan and tadalafil (10 mg/40 mg) branded as PrOpsynvi for pulmonary arterial hypertension has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Macitentan (macitentan)
• PrOpsynvi
• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Humanis Saglık Anonim Sirketi | Conditions: PAH | Phase 1 | Status: COMPLETED